On April 7, 2026, in support of the Trump Administration’s ongoing reorganization of the DOJ, Acting Attorney General Todd Blanche (“Acting AG Blanche”) announced the establishment of the National Fraud Enforcement Division,...more
On January 30, 2026, Representative Michael Lawler introduced H.R. 7291, the “GRAS Oversight and Transparency Act.” H.R. 7291 is the latest congressional effort to address longstanding concerns about the federal regulatory...more
A newly introduced House Bill, H.R. 7366, titled the Dietary Supplement Regulatory Uniformity Act, would amend the Federal Food, Drug, and Cosmetic Act (“FDCA”) to expressly clarify and affirm the Food and Drug...more
On August 30, an official at the United States Department of Health and Human Services (HHS) released one of the most significant announcements made at the federal level concerning marijuana reclassification. In a letter...more
9/13/2023
/ Biden Administration ,
Cannabis Products ,
Controlled Substances ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Deregulation ,
Healthcare ,
Marijuana ,
Medical Marijuana ,
Patient Access ,
Regulatory Reform ,
Regulatory Requirements